Cited by 931Tryptophan and brain disordersSchizophrenia research and treatmentNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.

Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

Open access

Khandaker, Golam M, Cousins, Lesley, Deakin, Julia, Lennox, Belinda R, Yolken, Robert, Jones, Peter B·2015·The Lancet Psychiatry

DOI 10.1016/s2215-0366(14)00122-9PMC PMC4595998

Open this paper in CoChat — free account

Abstract

Complex interactions between the immune system and the brain might have important aetiological and therapeutic implications for neuropsychiatric brain disorders. A possible association between schizophrenia and the immune system was postulated over a century ago, and is supported by epidemiological and genetic studies pointing to links with infection and inflammation. Contrary to the traditional view that the brain is an immunologically privileged site shielded behind the blood-brain barrier, studies in the past 20 years have noted complex interactions between the immune system, systemic inflammation, and the brain, which can lead to changes in mood, cognition, and behaviour. In this Review, we describe some of the important areas of research regarding innate and adaptive immune response in schizophrenia and related psychotic disorders that, we think, will be of interest to psychiatric clinicians and researchers. We discuss potential mechanisms and therapeutic implications of these findings, including studies of anti-inflammatory drugs in schizophrenia, describe areas for development, and offer testable hypotheses for future investigations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s2215-0366(14)00122-9

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Immunobiology: the immune system in health and disease
(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,111
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848

Show all 135 references

Sorted by citations

Items 601–700 of 931

Genomics-driven integrative analysis highlights immune-related plasma proteins for psychiatric disorders
Gong, W., Guo, P., Liu, L., Yan, R., Liu, S., Wang, S., Xue, F., Zhou, X., Sun, X., & Yuan, Z. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.10.126 · Cited by 4
Inflammation biomarkers and neurobehavioral performance in rural adolescents
Amdemicael, B., Yang, K., Chronister, B. N. C., Mackey, C., Tu, X. M., Gahagan, S., Martínez, D., Checkoway, H., Jacobs, D. R., Suárez-Torres, J., et al. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100912 · Cited by 4
Behavioral Abnormalities, Cognitive Impairments, Synaptic Deficits, and Gene Replacement Therapy in a CRISPR Engineered Rat Model of 5p15.2 Deletion Associated With Cri du Chat Syndrome
Shen, J., Wang, Y., Liu, Y., Lan, J., Long, S., Li, Y., Chen, D., Yu, P., Zhao, J., Wang, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202415224 · Cited by 4
Kynurenine amplifies tetrahydrocannabinol-induced sensorimotor impairment and classic “tetrad” effects in mice
Bilel, S., Corli, G., Tiziani, E., Chirenti, D., Dall’Acqua, S., Comai, S., Ferraro, L., Marti, M., & Beggiato, S. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111342 · Cited by 4
Implications of de novo mutations in guiding drug discovery: A study of four neuropsychiatric disorders
So, H., & Wong, Y. H. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.12.015 · Cited by 4
Lack of Association between the IL6R Gene Asp358Ala Variant (rs2228145), IL-6 Plasma Levels, and Treatment Resistance in Chilean Schizophrenic Patients Treated with Clozapine
Álvaro Cavieres, F., Campos‐Estrada, C., Moya, Y., Maldonado, R., González-Vargas, R., Bustamante, M. L., & Moya, P. R. (2019) · Schizophrenia Research and Treatment · doi:10.1155/2019/5601249 · Cited by 4
Nucks1 gene polymorphism rs823114 is associated with the positive symptoms and neurocognitive function of patients with schizophrenia in parts of southern China
Xia, W., Xu, X., Luo, X., Yin, J., Liang, C., Zhu, J., Nong, X., Zhu, X., Ning, F., Gu, S., et al. (2021) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000285 · Cited by 4
Primate-specific retrotransposons and the evolution of circadian networks in the human brain
Li, M., & Larsen, P. A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.049 · Cited by 5
Correlation Between Schizophrenia and Coronavirus Disease in North Sumatera, Indonesia: A Correlative Analytical Study
Amin, M. M., Futrawan, R., & Husada, M. S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.896623 · Cited by 4
Higher stress response and altered quality of life in schizophrenia patients with low membrane levels of docosahexaenoic acid
Adrien, V., Bosc, N., Fumat, H., Tessier, C., Ferreri, F., Mouchabac, S., Tareste, D. C., & Nuss, P. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1089724 · Cited by 4
Neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-α (TNF-α) levels in patients with schizophrenia
Çakıl, A. G., Kaya, H., Nural, A. S., Çakmak, I. B., Okay, İ. T., & Göka, E. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06346-2 · Cited by 4
Multiple myeloma, IL6, and risk of schizophrenia: A Mendelian randomization, transcriptome, and Bayesian colocalization study
Lin, S., Gao, B., Xu, R., Shang, H., Xiong, Y., Zhou, J., Yang, Z., Jiang, C., & Yan, S. (2024) · eJHaem · doi:10.1002/jha2.890 · Cited by 4
Genetics of suicide ideation. A role for inflammation and neuroplasticity?
Turiaco, F., Iannuzzo, F., Bruno, A., & Drago, A. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01836-6 · Cited by 4
Transcriptional Profile of Pyramidal Neurons in Chronic Schizophrenia Reveals Lamina-Specific Dysfunction of Neuronal Immunity
Wu, X., Shukla, R., Alganem, K., DePasquale, E. A. K., Reigle, J. K., Simmons, M. S., Hahn, C.-G., Haroutunian, V. H., Meller, J., Meador‐Woodruff, J. H., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.892 · Cited by 4
A Reflection Upon the Contribution of Retinal and Cortical Electrophysiology to Time of Information Processing in Psychiatric Disorders
Schwitzer, T., Leboyer, M., & Schwan, R. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.856498 · Cited by 4
Increased blood–brain barrier leakage in schizophrenia spectrum disorders compared to healthy controls in dynamic contrast-enhanced magnetic resonance imagingPreprint
Moussiopoulou, J., Yakimov, V., Rauchmann, B., Toth, H., Melcher, J., Jäger, I. M., Lutz, I., Kallweit, M. S., Papazov, B., Seelos, K., et al. (2023) · medRxiv · doi:10.1101/2023.12.12.23299782 · Cited by 4
Characteristics and Outcomes of Psychiatric Inpatients With Severe Mental Illness and COVID-19
Yalçin, M., Güngör, E. S., Ergelen, M., Keleş, D. B., Tüzer, M. Y., Baş, T. Ö., Güneş, M., Genç, D., Kırşavoğlu, B., Metin, M., et al. (2021) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001450 · Cited by 6
Gastrointestinal (GI)-lung-brain axis
Bazacliu, C., Roig, J. C., & Neu, J. (2025) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2025.101639 · Cited by 3
Sex-specific associations between Neutrophil-Percentage-to-Albumin Ratio(NPAR) and Neutrophil-to-Lymphocyte Ratio (NLR) with positive and negative symptoms in schizophrenia
Zhu, Y., Ren, J., & Fu, Z. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07373-3 · Cited by 3
Assessment of intestinal barrier integrity and associations with innate immune activation and metabolic syndrome in acutely ill, antipsychotic-free schizophrenia patients
Mukherjee, K., Guest, P. C., Nussbaumer, M., Dudeck, L., Asl, L. S., Meyer-Lotz, G., Dobrowolny, H., Borucki, K., Bernstein, H., Link, A., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03584-3 · Cited by 2
Identification and Validation of Immuno-Inflammatory Neuroimaging Markers Across Major Psychiatric Disorders
Tang, L., Gong, X., Wei, X., Tang, R., Ren, Y., Zhao, P., Xie, C., Cheng, W. D., Zhu, R., Tang, Y., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.10.004 · Cited by 3
Midbrain microglial and macrophage mRNAs distinguish neuroinflammatory schizophrenia from bipolar disorder
Victoriano, G. M., Zhu, Y., Kostoglou, Y., Walker, A. K., Middleton, F. A., Massa, P. T., Eggen, B. J. L., Webster, M. J., Sommer, I. E., & Weickert, C. S. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106276 · Cited by 5
Protein glycoxidation in neuropsychiatric disorders—from basic research to clinical practice
Orlof, W., & Maciejczyk, M. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104190 · Cited by 3
Nano-carriers for brain disorders targeting the blood brain barrier (BBB) crossing strategies
Gupta, K. R., Dabhekar, S., Dixit, M., & Umekar, M. J. (2021) · Indian Journal of Pharmacy and Pharmacology · doi:10.18231/j.ijpp.2020.035 · Cited by 4
The differences in serum C1q levels between first-episode patients with bipolar disorder and major depressive disorder
Chen, Q., Sun, T., Li, D., Zhao, Z., & Li, Y. (2022) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2022.111042 · Cited by 3
Comparative estimation of the effects of antihypertensive medications on schizophrenia occurrence: a multinational observational cohort study
Lee, D. Y., Kim, C., Kim, J., Yun, J., Lee, Y., Chui, C. S. L., Son, S. J., Park, R. W., & You, S. C. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05578-6 · Cited by 3
Risperidone-induced bioenergetic disruption in the isolated human peripheral blood monocytes
Alenezi, B. T., Doghaither, H. A. A., Al-Ghafari, A. B., & Elmorsy, E. M. (2024) · Toxicology in Vitro · doi:10.1016/j.tiv.2024.105936 · Cited by 3
A comprehensive metabolomic and lipidomic study of olanzapine in the treatment of first-episode schizophrenia
Dai, S., Long, Y., Xiao, J., Wang, Y., Wang, X., Shao, P., Huang, M., Xu, Y., Liu, F., Tang, Y., et al. (2025) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2025.104387 · Cited by 4
The Common Biological and Social Bases for Physical and Mental Disorders: Focus on Inflammation and Neuroendocrine System
Moussiopoulou, J., & Falkai, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-81802-8_4 · Cited by 4
α7 nicotinic acetylcholine receptor, activated glia, and cognitive impairment in schizophrenia: a dual-tracer PET study
Wakuda, T., Yokokura, M., Magata, Y., Suzuki, C., Murayama, C., Goto, T., Tamayama, T., Kameno, Y., Iwabuchi, T., Isobe, T., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03162-2 · Cited by 3
Comparing the Metabolic, Systemic, and Neuropsychiatric Impacts of Olanzapine and Clozapine in Patients with Schizophrenia
Alharbi, N. S., Hamdy, N. A., Aboubakr, E. M., Alharbi, M., Ali, M. A. S., Alharbi, G., & El‐Mallah, A. (2025) · Pharmaceuticals · doi:10.3390/ph18091314 · Cited by 4
A study of anti-gliadin antibodies in first-episode patients with schizophrenia among a Chinese population
Yang, H., Jiang, Y., Chen, Z., Wu, J., Qiu, C., & Meng, Q. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.161 · Cited by 3
Association of Genes for Proinflammatory Cytokines and Depression
Лежейко, Т. В., Andryushchenko, A. V., Коровайцева, Г. И., Kondratyev, N. V., Габаева, М. В., Крикова, Е. В., & Голимбет, В. Е. (2019) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-019-00796-y · Cited by 3
The effect of electroconvulsive therapy on hematologic inflammatory markers in schizophrenia in association with type of antipsychotic medication
Önen, S., & Taymur, İ. (2020) · The European Research Journal · doi:10.18621/eurj.586551 · Cited by 3
Systemic concentration of apelin, but not resistin or chemerin, is altered in patients with schizophrenia
Kozłowska, E., Brzezińska‐Błaszczyk, E., Wysokiński, A., & Żelechowska, P. (2021) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001523 · Cited by 3
The specific phenotype of depression in recent onset schizophrenia spectrum disorders: A symptom profile and network comparison to recent onset major depressive disorder without psychotic features
Herniman, S. E., Wood, S. J., Cotton, S., Allott, K., Davey, C. G., Berk, M., Phillips, L., Liemburg, E. J., Castelein, S., Veling, W., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.11.048 · Cited by 3
Metabolic responses in the cortex and hippocampus induced by Il-15rα mutation
He, Y., Ge, L., Tong, F., Zheng, P., Yang, J., Zhou, J., Sun, Z., Wang, H., Yang, S., Li, Y., et al. (2022) · Molecular Omics · doi:10.1039/d2mo00105e · Cited by 3
Maternal Infection during Pregnancy and Attention-Deficit Hyperactivity Disorder in Children: A Systematic Review and Meta-Analysis
Ayubi, E., & Mansori, K. (2022) · Iranian Journal of Public Health · doi:10.18502/ijph.v51i12.11458 · Cited by 5
The immunopsychiatry of early-onset psychosis
Wedervang‐Resell, K., & Szabó, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89832-4.00013-5 · Cited by 3
Animal Inflammation-Based Models of Neuropsychiatric Disorders
Demin, K. A., Zabegalov, K. A., Kolesnikova, T. O., Galstyan, D. S., Kositsyn, Y. M., Costa, F. V., de Abreu, M. S., & Kalueff, A. V. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_5 · Cited by 3
NEUROTROPIC PARASITIC INFECTIONS ASSOCIATED WITH PSYCHIATRIC DISORDERS: A REVIEW ARTICLE
ELSHAFEY, M., ELSHAFEY, M., ELBAITAR, S., Zayed, M. A., OTHMAN, A., & Aaty, H. E. A. (2023) · Journal of the Egyptian Society of Parasitology · doi:10.21608/jesp.2023.297369 · Cited by 3
Exploration on the potential efficacy and mechanism of methyl salicylate glycosides in the treatment of schizophrenia based on bioinformatics, molecular docking and dynamics simulation
Wang, X., Ma, J., Dong, Y., Ren, X., Li, R., Yang, G., She, G., Tan, Y., & Chen, S. (2024) · Schizophrenia · doi:10.1038/s41537-024-00484-y · Cited by 3
Lower plasma tumor necrosis factor-α is associated with symptomatic remission in patients with schizophrenia
Asada, R., Hori, H., Gotoh, L., Yasumatsu, K., Iida, H., & Kawasaki, H. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.07.029 · Cited by 3
The associations of peripheral interleukin alterations and hippocampal subfield volume deficits in schizophrenia
Sun, Y., Wu, D., Yang, X., Tang, B., Xia, C., Luo, C., Gong, Q., Lui, S., & Hu, N. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae308 · Cited by 3
Using Task-fMRI to Explore the Relationship Between Lifetime Cannabis Use and Cognitive Control in Individuals With First-Episode Schizophrenia
Lesh, T. A., Rhilinger, J., Brower, R., Mawla, A. M., Ragland, J. D., Niendam, T. A., & Carter, C. S. (2024) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgae016 · Cited by 3
Impact of second-generation antipsychotics monotherapy or combined therapy in cytokine, lymphocyte subtype, and thyroid antibodies for schizophrenia: a retrospective study
Guo, X., Kong, L., Wen, Y., Chen, L., & Hu, S. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06141-z · Cited by 3
Peripheral blood complement factors C2 and C3 as biomarkers of clinical efficacy in patients with first-episode schizophrenia after aripiprazole treatment
Cao, Y., Liang, J., Dai, B., Shan, F., & Xia, Q. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06437-0 · Cited by 3
Comprehensive bioinformatics analysis identifies hub genes associated with immune cell infiltration in early-onset schizophrenia
Wu, S., Xue, T., Li, Y., Chen, W., & Ren, Y. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06499-8 · Cited by 3
Covid-19, not your normal flu: A case report on Covid-19 psychosis and mania in a Malaysian hospital
Wong, R. P. Y., & George, P. (2022) · Malaysian Family Physician · doi:10.51866/cr1369 · Cited by 3
RETRACTED: Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double‐blind, randomized, placebo‐controlled trial
Abdallah, M. S., Mosalam, E. M., Hassan, A., Ramadan, A. N., Omara‐Reda, H., Zidan, A. A., Samman, W. A., & Elberri, E. I. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14010 · Cited by 2
Retracted
Changes in the consumption of antiepileptics and psychotropic medicines after starting low dose naltrexone: A nation-wide register-based controlled before-after study
Raknes, G., & Småbrekke, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-51569-z · Cited by 3
Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysis
Bortolasci, C. C., Marx, W., Walker, A. J., Hasebe, K., Kavanagh, B. E., Morris, M. J., Mohebbi, M., Turner, A., Gray, L. J., Berk, L., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035080 · Cited by 3
Psychoneuroimmunology
Aretouli, E., & Ojeda, N. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_963-1 · Cited by 3
Different roles of microbiota and genetics in the prediction of treatment response in major depressive disorder
Han, K. Q., Ji, L., Xie, Q., Liu, L., Wu, X., He, L., Shi, Y., Zhang, R., He, G., Dong, Z., et al. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.03.036 · Cited by 2
Viewing Psychiatric Disorders Through Viruses: Simple Architecture, Burgeoning Implications
Kong, L., Zhu, B., Zhuang, Y., Lai, J., & Hu, S. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01443-y · Cited by 2
Cell-free DNA in extracellular vesicles: A candidate biomarker of schizophrenia
Bai, Y.-L., Ma, S.-F., Qi, D., Guo, C., Liu, P., & He, K. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i8.107404 · Cited by 2
Exploration of Novel Biomarkers Through a Precision Medicine Approach Using Multi‐Omics and Brain Organoids in Patients With Atypical Depression and Psychotic Symptoms
Ahn, I., Chang, S., Lee, J., Choi, S. H., Han, J., & Kim, Y. (2025) · Advanced Science · doi:10.1002/advs.202508383 · Cited by 2
Microfluidic biosensors and devices for brain tumor diagnosis and monitoring
Allela, O. Q. B., Alkhazali, W. H., Arora, V., Prahlad, P., Mohanty, B., Dhyani, A., Uppal, S., Aliev, M. A., Sameer, H. N., Yaseen, A., et al. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120796 · Cited by 2
Peripheral inflammation mediates cognitive deficits in drug-naive schizophrenia through hippocampal-thalamo-visual circuitry dysfunction
Gou, N., Ma, Q., Jia, M., Qi, Z., Gao, Y., Wang, W., Ma, X., & Fan, Y. (2026) · Schizophrenia · doi:10.1038/s41537-025-00719-6 · Cited by 3
First Case-Control Study of Intestinal Parasites in Follow-up Schizophrenia Patients: Are We Overlooking the Role of These Agents?
YALNIZ, Z., Bulu, E., Kavla, Y., Sapmaz, B., Çalışkan, R., Poyraz, C. A., Öner, Y. A., Demirel, Ö. F., & Akgül, Ö. (2021) · Istanbul Medical Journal · doi:10.4274/imj.galenos.2021.01058 · Cited by 2
Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond
Nuss, P., Corruble, E., Baloche, E., Garay, R. P., & Llorca, P. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2108706 · Cited by 2
Link Between the Immune System and Aggression
Takahashi, A., & Russo, S. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-98711-4_146-1 · Cited by 2
White blood cells and patients with psychiatric disorders needing seclusion: A retrospective non-interventional study
Roméo, B., Mazari, A., Ali-Diabacte, H., Lestra, V., Martelli, C., Benyamina, A., & Hamdani, N. (2023) · L Encéphale · doi:10.1016/j.encep.2023.02.001 · Cited by 2
Narrative review of the advances in the pharmacotherapeutic management of juvenile-onset schizophrenia
Crump, C., Good, M. E., Abuelazm, H., & El‐Mallakh, R. S. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2208269 · Cited by 4
The Modulated Role of Toxoplasma gondii on Eosinophils in Psychiatric Disorders after Cannabis Cessation
Roméo, B., Lestra, V., Martelli, C., Amirouche, A., Benyamina, A., & Hamdani, N. (2023) · Pathogens · doi:10.3390/pathogens12111333 · Cited by 2
Association between the HHEX polymorphism and delayed memory in first-episode schizophrenic patients
Zhu, Z. H., Yin, X. Y., Cai, Y., Jia, N. N., Wang, P. J., Qi, Q., Hou, W. L., Man, L. J., & Hui, L. (2024) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2024.100304 · Cited by 2
Functional foods and neuroinflammation: Focus on autism spectrum disorder and schizophrenia
Matrisciano, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91747-6.00012-3 · Cited by 2
Aberrant Hippocampal Neuroregenerative Plasticity in Schizophrenia: Reactive Neuroblastosis as a Possible Pathocellular Mechanism of Hallucination
Irakkam, M. P. B. D., Joseph, J. H. M., & Kandasamy, M. (2024) · Neurosignals · doi:10.33594/000000712 · Cited by 2
Th17-Mediated Immune Responses in Pathogenesis of Neuroinflammatory Disorders
Pourgholaminejad, A., & Tahmasebinia, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-60006-7_3 · Cited by 2
Association between psychiatric symptoms with multiple peripheral blood sample test: a 10-year retrospective study
Qiu, J., Yu, C., Kuang, Y., Hu, Y., Zhu, T., Qin, K., & Zhang, W. Y. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1481006 · Cited by 2
Dynamic Real‐Time Biosensing Enabled Biorhythm Tracking for Psychiatric Disorders
Huizer, K., Banga, I. K., Kumar, R. M., Muthukumar, S., & Prasad, S. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.2021 · Cited by 2
Ambient coarse particulate matter pollution and hospital admissions for schizophrenia
Ma, Y., Bai, L., Jiang, Y., Wang, J., Chen, W., Li, Y., Tian, Y., & Wu, S. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.01.004 · Cited by 2
Association between autoimmune disease and neurodevelopmental disorder: a Mendelian randomization analysis
Qin, J., Zhang, Y., Hu, R., Lin, M., Yu, R., Hua, Y., & Li, Y. (2025) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-025-01910-2 · Cited by 2
Novel opportunities for treating complex neuropsychiatric and neurocognitive conditions based on recent developments with xanomeline
Pavlov, V. A. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1593341 · Cited by 2
Aberrant Expression of TH2LCRR and GATA3 in Peripheral Blood Mononuclear Cells of Patients with Acute-Phase Schizophrenia: Integrative Bioinformatics Analysis and Experimental Study
Moghiseh, E., Massoudifar, A., Davoodian, N., Mousavi, P., Afsharpour, S., & Mahmoodi, M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05060-8 · Cited by 2
Association between keloid and mental disorders: perspective from genetic evidence
Zhan, Y., Tong, Y., Wu, X., Wang, Z., & Zhang, G. (2025) · Annals of General Psychiatry · doi:10.1186/s12991-025-00579-5 · Cited by 2
Memantine Rescues Neurosyphilis-Related Schizophrenic-like Features and Cognitive Deficit
Chen, W.-C., Wang, H., Chen, P.-A., Chen, I.-C., & Chen, Y.-C. (2019) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000347 · Cited by 2
Microchimerism may be the cause of psychiatric disorders
Demirbek, B., & Osman, D. (2019) · Archives of Psychiatry and Mental Health · doi:10.29328/journal.apmh.1001009 · Cited by 2
Black Seed (Nigella sativa) Efficacy in Improving Clinical Symptoms and Interleukin-6 Levels Schizophrenic Patients
Purwatiningsih, S., Syamsuddin, S., Lisal, S. T., Liaury, K., Bahar, B., & Yustisia, I. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.7482 · Cited by 2
DNA Hyper-methylation Associated With Schizophrenia May Lead to Increased Levels of Autoantibodies
Wei, H., Yuan, Y., Zhu, C., Ma, M., Yang, F., Lu, Z., Wang, C., Deng, H., Zhao, J., Tian, R., et al. (2022) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgac047 · Cited by 2
Saffron in Phytotherapy: Pharmacological Properties and Medicinal Uses
Zouagui, R., & Sbabou, L. (2022) · Compendium of plant genomes · doi:10.1007/978-3-031-10000-0_15 · Cited by 2
A study of post‐traumatic stress disorder in schizophrenic patients 35 years after experiencing the Tangshan earthquake
Ma, W., Lei, R., Sun, Y., Liang, X., Zhang, S., Wang, C., Tang, Y., Wang, G., Li, H., & Yu, Z. (2023) · Brain and Behavior · doi:10.1002/brb3.2963 · Cited by 2
Unrevealing the shared genetic mechanisms underlying C-reactive protein and schizophrenia
Yang, Z., Li, D., Hé, Y., Chen, X., & Li, Z. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110785 · Cited by 2
Posibles mecanismos de acción de la terapia electroconvulsiva en esquizofrenia: revisión de la evidencia disponible en investigación con seres humanos
Marcelo Arancibia, M., Vargas, C., Abarca, M., Fernández, J., Peña, D., & Álvaro Cavieres, F. (2022) · Revista médica de Chile · doi:10.4067/s0034-98872022001101493 · Cited by 2
Association of atopic dermatitis with schizophrenia and schizoaffective disorder
Fan, R., Chen, G. F., Leasure, A. C., Johnson, M. C., Damsky, W., & Cohen, J. M. (2023) · Archives of Dermatological Research · doi:10.1007/s00403-023-02674-7 · Cited by 2
A Matched Case-Control Study of the Serum Level and Gene Expression of IL-6 and IL-12 in Patients with Schizophrenia Spectrum Disorder: An Azeri Acute Phase/Recent-Onset Psychosis Survey (ARAS) Study
Shafiee‐Kandjani, A. R., Asadi, M., Farhang, S., Shanebandi, D., Asadi, M., Mohagheghi, A., & Bruggeman, R. (2024) · Archives of Neuroscience · doi:10.5812/ans-142694 · Cited by 2
Oligogenic rare variant contributions in schizophrenia and their convergence with genes harbouring de novo mutations in schizophrenia, autism and intellectual disability: Evidence from multiplex familiesPreprint
John, J., Kukshal, P., Triptish Bhatia, A., Harripaul, R., Nimgaonkar, V. L., Deshpande, S. N., & Thelma, B. K. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/829101 · Cited by 2
Impairment of methylglyoxal detoxification systems causes mitochondrial dysfunction and schizophrenia-like behavioral deficitsPreprint
Toriumi, K., Berto, S., Koike, S., Usui, N., Dan, T., Suzuki, K., Miyashita, M., Horiuchi, Y., Yoshikawa, A., Sugaya, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.08.192906 · Cited by 2
Biased activation of inflammation pro-resolving receptors as an evolving supportive strategy in schizophrenia treatment
Kalinkovich, A., Pouyrovsky, M., Nasyrova, R. F., & Livshits, G. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.01.003 · Cited by 1
Reprint of: Internalising symptoms mediate the longitudinal association between childhood inflammation and psychotic-like experiences in adulthood
Francesconi, M., Minichino, A., Khandaker, G. M., Midouhas, E., Lewis, G., & Flouri, E. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.11.009 · Cited by 1
Self-citation
Smoking Habits and Attitudes toward Smoking in Patients with Severe Mental Illness in Residential Facilities in Insular Greece
Botsari, I. A., Marouli, G., Arvanitaki, A., & Peritogiannis, V. (2023) · Healthcare · doi:10.3390/healthcare11050642 · Cited by 1
Pathogenese der Schizophrenie(n)
Yakimov, V., Falkai, P., & Wagner, E. M. (2023) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-2099-7560 · Cited by 1
Prospective Intergenerational Consequences of Paternal Stress Experiences on Offspring Immune Health
Guerrin, C. G. J., Trompke, M., & Pang, T. Y. (2024) · Springer eBooks · doi:10.1007/978-3-031-59286-7_10 · Cited by 1
Diagnostic value and correlation analysis of serum cytokine levels in patients with multiple system atrophy
Chen, X., Chen, S., Lai, X., Fu, J., Yang, J., Ou, R., Zhang, L., Wei, Q., Guo, X., & Shang, H. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1459884 · Cited by 1
«Cytokine storm» as an immunopathologic reaction in pregnant women in the first trimester
Lyashenko, E. N., Aramyan, E. E., & Zinchenko, M. S. (2024) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20242405119 · Cited by 1
Causal relationship between mental disorders and abdominal aortic aneurysm: Insights from the genetic perspective.
Deng, M.-G., Chai, C., Wang, K., Zhao, Z.-H., Nie, J., Liu, F., Liang, Y.-H., & Liu, J.-W. (2025) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111277 · Cited by 1
Psychiatric morbidity in people with autoimmune arthritides as a model of inflammatory mechanisms in mental disorders
Formánek, T., Mladá, K., Mohr, P., Lim, M. F., Olejarová, M., Pavelká, K., Winkler, P., Osimo, E. F., Jones, P. B., & Hušáková, M. (2025) · BMJ Mental Health · doi:10.1136/bmjment-2024-301506 · Cited by 2
Self-citation
Age-Dependent Correlation between Immune Parameters and Symptoms in Young Adults with Schizophrenia
Zhu, C., Guan, X., Chen, N., Xiu, M., & Huang, Y. (2025) · Current Neuropharmacology · doi:10.2174/1570159x23666250407092539 · Cited by 1
Interaction between the brain and multiple organ systems in schizophrenia
Lin, J. S., Feng, S., Wu, Z.-Y., Dong, L., Yin, D., Hong, Z., Jia, H., & Ning, Y. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i8.107696 · Cited by 1
The Role of Antipsychotic Treatments in Neutrophil/Lymphocyte, Platelet/Lymphocyte, Monocyte/Lymphocyte, Monocyte/HDL Ratios and Systemic Immune Inflammatory Index Values for Patients with Schizophrenia
Aydın, M., & Söylemez, H. (2025) · Genel Tıp Dergisi · doi:10.54005/geneltip.1645072 · Cited by 1

Authors: Khandaker, G. M., Cousins, L., Deakin, J., Lennox, B. R., Yolken, R., & Jones, P. B.
Affiliations: University of Cambridge (GB)
University of Oxford (GB)
Johns Hopkins University (US)
ORCID: Khandaker, Golam M
Cousins, Lesley
Lennox, Belinda R
Yolken, Robert
Jones, Peter B
Venue: The Lancet Psychiatry
Publisher: Elsevier BV
Published: 2015-03
Volume: 2
Issue: 3
Pages: 258-270
ISSN: 2215-0366 (ISSN-L)
DOI: 10.1016/s2215-0366(14)00122-9
PMC: PMC4595998
OpenAlex: W2121637331
Cited by: 926
References: 135
Citations by year: 2026: 82 · 2025: 81 · 2024: 111 · 2023: 104 · 2022: 94 · 2021: 105 · 2020: 78 · 2019: 86 · 2018: 62 · 2017: 63 · 2016: 54 · 2015: 5
FWCI: 3.45
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet Psychiatry (publishedVersion)
PubMed (publishedVersion)
Bristol Research (University of Bristol) (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Apollo (University of Cambridge) (acceptedVersion)
Explore Bristol Research (submittedVersion)
Funders: Wellcome Trust to GMK ((094790/Z/10/Z; 2010-'13))
National Institute of Mental Health ((MH-94268))
Wellcome Trust ((095844/Z/11/Z and 088869/Z/09/Z))
National Institute for Health Research ((RP-PG-0606–1335))
Topics: Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: schizophrenia, inflammation, immunity, innate immune response, adaptive immune response, infection, blood-brain barrier, anti-inflammatory agents, psychosis, pathophysiology, treatment
MeSH terms: Humans, Immune System, Inflammation, Schizophrenia, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks